Homepage - JADPRO

For updated information about JADPRO Live 2021, please visit JADPROLive.com

CURRENT ISSUE Current Issue Cover

VOL 12 NO 3 • APR 2021

IN THIS ISSUE

JADPRO Live Virtual 2020: Learning Today, Leading Tomorrow

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, FAAN

Advanced Practitioner Leadership in Times of Crisis

Presented by Gabrielle Zecha,(1) PA-C, MHA, Andrew S. Guinigundo,(2) MSN, RN, CNP, ANP-BC, David Johnson,(3) PA-C, and Sara Toth,(4) RN, APRN, FNP-C, AOCNP®, AGN-BC

Words Matter: Use of Respectful Language in Oncology

Presented by Laura J. Zitella,(1) MS, RN, ACNP-BC, AOCN®, and Tatiana M. Prowell,(2) MD

Are Current Metrics Adequate to Demonstrate the Value of Oncology Advanced Practitioners?

Presented by Jason Astrin, DMSc, MBA, PA-C, DFAAPA

Abemaciclib-Associated Adverse Events Sa...

Treatment with abemaciclib, an orally available in...

FDA Pipeline Priority Reviews of Treatme...

Recently, the U.S. Food and Drug Administration (F...

First-Line Single-Agent Carboplatin vs C...

In a phase II trial reported in JAMA Oncology, Fal...

Antiviral T Cells for BK Virus–Associate...

A phase II trial has found found that BK virus (BK...

More News From Today

EDITORIALS & COMMENTARY

https://www.advancedpractitioner.com/issues/volume-11,-number-6-(aug-2020)/asco20-virtual-scientific-program-takeaways-for-the-advanced-practitioner.aspx

CAR T-cell therapy is rapidly emerging as a promising treatment for many hematologic malignancies...

Rare Myeloproliferative Neoplasm w/CSF3R

Cases of chronic neutrophilic leukemia (CNL) are extremely rare and easily missed...

Management of Carcinoid Syndrome

Diarrhea is often a presenting symptom in patients with neuroendocrine tumors...

APs: Collaborators in Radiation Oncology

Advanced practitioners, including physician assistants and nurse practitioners, are medical professionals with...

Axicabtagene Ciloleucel: CAR T-Cell Therapy

Axicabtagene ciloleucel (axi-cel) is an anti-CD19 CAR T-cell therapy that has demonstrated efficacy...

More Editorials & Commentary

PREVIOUS HIGHLIGHTS

Gemcitabine/Eribulin in Cisplatin-Inelig...

In the final analysis from a phase II California C...

Deintensified Chemoradiotherapy for HPV-...

In a phase II trial reported in the Journal of Cli...

USPSTF Recommendation on Risk Assessment...

As reported in JAMA, the U.S. Preventive Services ...

Incidence of HPV-Associated Head and Nec...

In a study by Mahal et al published in Cancer Epid...

Racial Reporting and Representation in O...

New research published by Loree et al in JAMA Onco...

More Highlights

LATEST TWEETS

Join us during a special webinar for manageme...

about 1 days ago via web

Check out a new way to learn about patient ma...

about 6 days ago via web

Join us for a webinar discussing management a...